Le Lézard
Classified in: Health
Subjects: MAV, CFG

NOTICE TO THE MEDIA - Government of Canada to make an announcement on palliative care


OTTAWA, ON, April 25, 2024 /CNW/ - The Honourable David J. McGuinty, Member of Parliament for Ottawa South,  on behalf of the Honourable Mark Holland, Minister of Health, will hold a news conference to announce funding to improve palliative care.

MP McGuinty will be available to answer questions from the media following his remarks.

Date
April 29, 2024

Time
11:30 AM (ET)

Location

Roger Neilson Children's Hospice
399 Smyth Road
Ottawa, ON

A Zoom link is also available for journalists to ask questions virtually.

Zoom link: https://hc-sc-gc-ca.zoom.us/j/62856054643  
Passcode: 145477

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Health Canada (HC)


These press releases may also interest you

at 16:15
Exelixis, Inc. today announced that members of the company's management team will participate in fireside chats at the following investor conferences in May: BofA Securities 2024 Health Care Conference: Exelixis is scheduled to present at 2:20...

at 16:10
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Citizens JMP Life Science Conference on May 14, 2024 at 6:00am...

at 16:10
Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell Engager (TRACTr) and Tumor Activated...

at 16:10
AbCellera today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. "We continue to execute on advancing our internal pipeline,...

at 16:10
Veracyte, Inc. today announced financial results for the first quarter ended March 31, 2024. "We had a strong start to 2024, driven by robust growth from our market-leading Decipher Prostate and Afirma tests. We executed upon our strategies to...

at 16:10
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced business updates and financial results for the first quarter ended March 31, 2024. Recent...



News published on and distributed by: